Clinical trial EFC15858/CARMEN-LC03
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel in Previously Treated metastatic Non-Squamous Non-Small Cell Lung Cancer patients with CEACAM5 positive tumors
| Cancers | |
|---|---|
| Organ | Lung |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Sanofi-Aventis |
| EudraCT Identifier | 2019-001273-81 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04154956 |
| Last update |